Just diagnosed with Idiopathic pulmonary hemosiderosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Idiopathic pulmonary hemosiderosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Idiopathic pulmonary hemosiderosis hub →Overview
Idiopathic pulmonary hemosiderosis is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Idiopathic pulmonary hemosiderosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:99931 · OMIM 178550, 235500 · ICD-10 E83.1+, J99.8* · GARD 0006763
Find care for Idiopathic pulmonary hemosiderosis
Authoritative references for Idiopathic pulmonary hemosiderosis
Research & market landscape for Idiopathic pulmonary hemosiderosis
Following Idiopathic pulmonary hemosiderosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Idiopathic pulmonary hemosiderosis — the real-world landscape behind the condition, in one place.
- Latest Idiopathic pulmonary hemosiderosis research on PubMed ↗
- Recruiting Idiopathic pulmonary hemosiderosis trials on ClinicalTrials.gov ↗
- Explore the Idiopathic pulmonary hemosiderosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Idiopathic pulmonary hemosiderosis and every rare condition. See how Tomeko works with industry →
Common questions
What is Idiopathic pulmonary hemosiderosis?
Idiopathic pulmonary hemosiderosis is a rare condition. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Idiopathic pulmonary hemosiderosis together in one place.
What are the symptoms of Idiopathic pulmonary hemosiderosis?
Symptoms of Idiopathic pulmonary hemosiderosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Idiopathic pulmonary hemosiderosis.
How is Idiopathic pulmonary hemosiderosis treated?
Treatment for Idiopathic pulmonary hemosiderosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Idiopathic pulmonary hemosiderosis, and review current options with them.
What causes Idiopathic pulmonary hemosiderosis — is it genetic?
The cause and inheritance of Idiopathic pulmonary hemosiderosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Idiopathic pulmonary hemosiderosis can explain what it means for you and your family.
I was just diagnosed with Idiopathic pulmonary hemosiderosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Idiopathic pulmonary hemosiderosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Idiopathic pulmonary hemosiderosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Idiopathic pulmonary hemosiderosis, filtered to your area.
Are there clinical trials for Idiopathic pulmonary hemosiderosis?
Tomeko shows live, recruiting studies for Idiopathic pulmonary hemosiderosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3
